New Allergan Tool against Glaucoma

Allergan has announced the registration in Australia of the first injectable gel implant, XEN Gel Implant, for leading global cause of irreversible blindness, glaucoma.

Pharmacists are encouraged to watch for patients struggling with multiple glaucoma eye drops to urge their return to their clinician to consider this new option which has led to around half of patients being free of drops within 12 months in some groups.

More information can be found on 

Allergan also offers dry eye solutions. See the education modules below for more information.

Source:, Thursday 16 August 2018


Related Education Modules

Optive® Eye Drops-Complete your daily routine Day+Night

Refresh® Eye Drops: Caring for Dry Eyes

100 pts